secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001193125-25-024057
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems receives Nasdaq delisting; stock to trade OTC from Feb 12
-----------------------------------------------------------------------

- Nasdaq Panel determined to delist T2 Biosystems common stock; trading suspended at open on Feb 12, 2025.
- Company violated Bid Price Rule (5550(a)(2)) and Market Value of Listed Securities Rule (5550(b)(2)).
- Company will not appeal; expects Nasdaq to file Form 25-NSE with SEC.
- Stock to trade under TTOO on OTC Markets starting Feb 12; plans to apply for OTCQX quotation.
- No assurance of continued trading liquidity or broker-dealer support on OTC market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312525024057/0001193125-25-024057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312525024057/d869925d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-024057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer